Functional assessment of cancer therapy questionnaire for breast cancer (FACT-B+4): Italian version validation
Adult
Aged, 80 and over
Reproducibility of Results
Breast Neoplasms
Middle Aged
breast cancer; fact-b; quality of life; questionnaire; validation; adult; aged; aged, 80 and over; breast neoplasms; cohort studies; female; humans; italy; language; middle aged; reproducibility of results; quality of life; surveys and questionnaires
3. Good health
Cohort Studies
03 medical and health sciences
0302 clinical medicine
Italy
Surveys and Questionnaires
Quality of Life
Humans
Female
Aged
Language
DOI:
10.7417/t.2018.2071
Publication Date:
2018-01-01
AUTHORS (10)
ABSTRACT
Improvements in breast cancer diagnosis and treatment led to an increased incidence of survivors' rate. The healthcare system has to face new problems related not only to the treatment of the disease, but also to the management of the quality of life after the diagnosis. The aim of this study was to validate the Italian version of the Functional Assessment of Cancer Therapy - Breast (FACT-B+4) questionnaire and to evaluate its reliability.The questionnaire was administered twice, with an interval of three days between each administration, to a cohort of women of the Breast Surgical Unit, PoliclincoUmberto I. Cronbach's alpha was used as a measure of the internal consistency of the Italian version.The Italian version of the tool was administered to 55 subjects. The Cronbach's alpha for most scores registered values >0.7, both at baseline and at the follow-up analysis, therefore the subscale showed good internal consistency.The Italian version of FACT-B+4 demonstrated acceptable reliability properties in the Breast Unit patients. The use of this questionnaire seemed to be effective and in line with the results derived from the English and Spanishversions. Internal consistency and validity had similar performance results.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....